January 27, 2025 03:53 PM ESTUpdated January 28, 01:23 PM
People
Cell/Gene Tx

Up­dat­ed: Cell ther­a­py biotech Affi­ni-T Ther­a­peu­tics re­duces staff

Kyle LaHucik

Senior Reporter

Affi­ni-T Ther­a­peu­tics laid off an undis­closed num­ber of em­ploy­ees last week, CEO Jak Knowles con­firmed in a post-pub­li­ca­tion email to End­points News on Tues­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Can Bill An­der­son save Bay­er?

Drug pol­i­cy vet­er­an at CMS to de­part on Fri­day

Up­dat­ed: Lil­ly joins Trump ad­min­is­tra­tion to an­nounce $27B man­u­fac­tur­ing com­mit­ment

Verve is lat­est gene edit­ing com­pa­ny to suf­fer set­back, as Ver­tex walks away from pact

FDA meet­ing to pick next win­ter's flu shot is can­celed, in omi­nous sign for US vac­cine pol­i­cy

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times